Navigation Links
Dr. Tamer Seckin Comments on the Effects of Endometriosis on Miscarriages and Infertility
Date:10/25/2013

New York, New York (PRWEB) October 25, 2013

Last Tuesday, October 15, marked the anniversary of National Pregnancy and Infant Loss Remembrance Day. Women who find themselves having a hard time getting pregnant and having a child without miscarriage may have endometriosis to blame. In hopes of decreasing the number of miscarriages and educating women of the disorder, Dr. Seckin, co-founder of the Endometriosis Foundation of America, offers insight on endometriosis and how the disorder affects the fertility of women.

Endometriosis, a chronic gynecologic disorder, has an immunological component that can lead to miscarriages. The disorder is one of the leading causes of infertility in women, where medical studies show that 30 – 50% of women with endometriosis are infertile, and 21% – 44% of infertile women have endometriosis. Luckily, with proactive treatment, women can increase the probability of pregnancy.

This spring, leading gynecologic doctors and experts met at the Fourth Annual Scientific and Surgical Symposium sponsored by the Endometriosis Foundation of America in New York City to discuss infertility and early pregnancy loss in endometriosis patients. While doctors commonly agree that endometriosis affects the uterine lining and interferes with embryo implantation, many doctors are beginning to realize endometriosis can affect the egg quality itself.

“Many women want to have the American dream: two kids, a dog, and a white picket fence,” said Dr. Seckin. “Endometriosis does not have to be the end of that dream. It is cruel that the disease has led to the devastating experience of pregnancy loss. Early diagnosis and intervention are the best treatments.”

Egg freezing is an option for young women who are worried and proactive about their future family building. For women suffering with endometriosis, especially those with recurrent pregnancy loss, it is recommended to use in-vitro fertilization and pre-implantation genetic diagnosis to help achieve a healthy pregnancy.

Endometriosis can also leave a destructive path in a patient’s pelvis. Dr. Seckin has seen a great number of his patients go on to have healthy pregnancies after completing an Advanced Laparoscopic Excision Surgery on their pelvis to eliminate the source of inflammation. Without the surgery, scar tissue and adhesions can form on the Fallopian tubes, making it extremely dangerous for the woman because she must terminate the pregnancy before the tube ruptures.

About Dr. Seckin:

Dr. Tamer Seckin has focused on the surgical treatment of endometriosis for decades and today is a well-regarded expert in the field. His New York City based practice, Dr. Seckin Endometriosis Surgery, is known for its warm, dedicated and continuous patient care, exceptional skill and thoroughness. He is also the co-founder of the Endometriosis Foundation of America. As a leading endometriosis specialist and laparoscopic surgeon, Dr. Seckin understands the frustration that affected individuals may feel. Dr. Seckin's treatment approach is the gold standard--Advanced Laparoscopic Excision Surgery (deep removal of all the disease). He performs almost scar-free surgery, which means less pain and cosmetically acceptable results.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11253644.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lice Tamers Brings FDA-Cleared LouseBuster™ Device to Suffolk County
2. Aptamers Market to Reach $2.1 Billion by 2018 at A CAGR of 49.24% - New Report by MarketsandMarkets
3. Aptamers Market - New Industry Research Report Is Now Available for Pre-Order at Transparency Market Research
4. AADR comments on review that validates association between oral health and heart health
5. Dr. Chiaravalloti of Kessler Foundation comments on trends in rehabilitation research in MS
6. Kettlebell Training Expert Lorna Kleidman Comments on an Article about Risks of Ibuprofen Use for Athletes
7. MyBloodWorks Creator Glen Ogle Comments on New Study Linking Hypertension During Pregnancy to Later Heart Trouble
8. Bioforce AG Announces Doctors Comments Showing Efficacy of Echinaforce for Immune Support Now On You Tube
9. Fitness Expert Lorna Kleidman Comments on Article Concerning Weight Loss as a New Year’s Resolution
10. Quorn Foods Inc. Comments on an Article Regarding a Year in Review for Philadelphia’s Meatless Meals and the Restaurants That Serve Them
11. Kettlebell Exercises Expert Lorna Kleidman Comments on New Fitness Technology Gadgets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the ... series, and attorneys from the firm’s global Life Sciences & Medical Technology Group have ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ... been recognized for adherence to the highest standards of trauma, maternity, cancer and ... the center's president and CEO, Dr. Daniel Messina. , Among the recognitions, the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the digital health platform ... by Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning ... serve more consumers who are managing chronic conditions or simply want to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coppin Insurance Agency, an ... families in and around the Cape Coral area, is embarking on a charity drive ... of Southwest Florida. , The Harry Chapin Food Bank of Southwest Florida works to ...
(Date:12/7/2016)... ... December 07, 2016 , ... Students ... have the unique opportunity to get hands-on experience in an emergency medical simulation, ... immersive experience to gain invaluable, real-life medical skills that are critical success in ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  A new study by a pair of Geisinger ... therapy to treat chronic pain is not only ineffective, ... consequences, including death. Palliative care physicians ... , M.D., authored the study which provides a review ... study was published in the December 2016 edition of ...
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... 2016 Mederi Therapeutics Inc . hat die behördliche Zulassung ... für gastroösophageale Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast ... of Endoscopy at Wuhan Union Hospital ...
Breaking Medicine Technology: